IMGN

Immunogen Inc
IMGN

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings
 

About: Immunogen Inc is a clinical-stage biotechnology company from the United States. Its focus is antibody-drug conjugate, or ADC, technology, which uses an antibody that fixes on a target (its antigen) found on tumor cells to deliver a specific cancer-killing agent.

Employees: 277

Healthcare Drug Manufacturers - General
Price charts implemented using Lightweight Charts™